Liquidia (LQDA) Change in Accured Expenses (2020 - 2026)
Liquidia (LQDA) posted quarterly Change in Accured Expenses of $14.5 million for Q1 2026, up 401.62% year-over-year from $2.9 million in Q1 2025, and down 55.63% quarter-over-quarter from $32.8 million in Q4 2025.
Liquidia (LQDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Liquidia's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $14.5 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 401.62% year-over-year to $14.5 million; the TTM figure through Mar 2026 stood at $73.9 million (up 32649.78% YoY), while the FY2025 annual figure was $54.5 million, up 937.04% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $14.5 million, down from $32.8 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $32.8 million in Q4 2025, with the low at -$4.8 million in Q1 2025.
- The 5-year median for Change in Accured Expenses is $1.8 million (2023), against an average of $4.9 million.
- Peak annual rise in Change in Accured Expenses reached 1913.33% in 2023, while the deepest fall reached 3781.43% in 2023.
- Liquidia's Change in Accured Expenses stood at $330000.0 in 2022, then jumped by 1913.33% to $6.6 million in 2023, then slumped by 70.38% to $2.0 million in 2024, then surged by 1564.28% to $32.8 million in 2025, then slumped by 55.63% to $14.5 million in 2026.
- Business Quant data shows LQDA's Change in Accured Expenses at $14.5 million in Q1 2026, $32.8 million in Q4 2025, and $17.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.38 Bn | 6.10 Bn | 160.92 Mn | 33.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.97 Mn |
| Jun 30, 2026 | 33.97 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Mar 31, 2026 | 14.53 Mn |
| Dec 31, 2025 | 32.75 Mn |
| Dec 31, 2025 | 32.75 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Sep 30, 2025 | 17.92 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Jun 30, 2025 | 8.68 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Mar 31, 2025 | -4.82 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Sep 30, 2024 | 3.59 Mn |
| Jun 30, 2024 | -968,000.00 |
| Jun 30, 2024 | -968,000.00 |
| Mar 31, 2024 | 668,000.00 |
| Mar 31, 2024 | 668,000.00 |